Bergmans HE[Author] - Search Results

Year	Number of Results
1975	1
1978	1
1979	3
1980	1
1981	1
1983	1
1988	2
1992	1
1996	1
2005	1
2008	1
2010	1
2012	1
2013	4
2014	1
2019	1
2021	1
2024	0

1

Transgenerational transfer of gene-modified T cells.

Cosgrove C, Dellacecca ER, van den Berg JH, Haanen JB, Nishimura MI, Le Poole IC, Bergmans HEN. Cosgrove C, et al. Among authors: bergmans hen. J Immunother Cancer. 2019 Jul 15;7(1):186. doi: 10.1186/s40425-019-0657-2. J Immunother Cancer. 2019. PMID: 31307533 Free PMC article.

2

General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.

Baldo A, van den Akker E, Bergmans HE, Lim F, Pauwels K. Baldo A, et al. Among authors: bergmans he. Curr Gene Ther. 2013 Dec;13(6):385-94. doi: 10.2174/15665232113136660005. Curr Gene Ther. 2013. PMID: 24195604 Free PMC article. Review.

3

Biotechnology and Biosafety Policy at OECD: Future Trends.

Kearns PWE, Kleter GA, Bergmans HEN, Kuiper HA. Kearns PWE, et al. Among authors: bergmans hen. Trends Biotechnol. 2021 Oct;39(10):965-969. doi: 10.1016/j.tibtech.2021.03.001. Epub 2021 Mar 19. Trends Biotechnol. 2021. PMID: 33752894 Free article.

4

Dot-blot hybridization method.

Bergmans HE, Gaastra W. Bergmans HE, et al. Methods Mol Biol. 1988;4:385-90. doi: 10.1385/0-89603-127-6:385. Methods Mol Biol. 1988. PMID: 21424648

5

Reappraisal of biosafety risks posed by PERVs in xenotransplantation.

Louz D, Bergmans HE, Loos BP, Hoeben RC. Louz D, et al. Among authors: bergmans he. Rev Med Virol. 2008 Jan-Feb;18(1):53-65. doi: 10.1002/rmv.559. Rev Med Virol. 2008. PMID: 17987669 Review.

6

Emergence of viral diseases: mathematical modeling as a tool for infection control, policy and decision making.

Louz D, Bergmans HE, Loos BP, Hoeben RC. Louz D, et al. Among authors: bergmans he. Crit Rev Microbiol. 2010 Aug;36(3):195-211. doi: 10.3109/10408411003604619. Crit Rev Microbiol. 2010. PMID: 20218764 Review.

7

Animal models in virus research: their utility and limitations.

Louz D, Bergmans HE, Loos BP, Hoeben RC. Louz D, et al. Among authors: bergmans he. Crit Rev Microbiol. 2013 Nov;39(4):325-61. doi: 10.3109/1040841X.2012.711740. Epub 2012 Sep 14. Crit Rev Microbiol. 2013. PMID: 22978742 Review.

8

Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines.

Louz D, Bergmans HE, Loos BP, Hoeben RC. Louz D, et al. Among authors: bergmans he. J Gene Med. 2005 Oct;7(10):1263-74. doi: 10.1002/jgm.794. J Gene Med. 2005. PMID: 15986492 Free PMC article. Review.

9

Environmental risk assessment of replication competent viral vectors applied in clinical trials: potential effects of inserted sequences.

van den Akker E, van der Vlugt CJ, Bleijs DA, Bergmans HE. van den Akker E, et al. Among authors: bergmans he. Curr Gene Ther. 2013 Dec;13(6):395-412. doi: 10.2174/156652321306140103221621. Curr Gene Ther. 2013. PMID: 24397527 Review.

10

Isolation and characterisation of dog uropathogenic Proteus mirabilis strains.

Gaastra W, van Oosterom RA, Pieters EW, Bergmans HE, van Dijk L, Agnes A, ter Huurne HM. Gaastra W, et al. Among authors: bergmans he. Vet Microbiol. 1996 Jan;48(1-2):57-71. doi: 10.1016/0378-1135(95)00133-6. Vet Microbiol. 1996. PMID: 8701578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year